No Data
No Data
MRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment
The medical and pharmaceutical community continues to embrace emerging technologies, beginning with mRNA that rose to fame during the COVID-19 pandemic.
The Investment Guide for the 2024 USA Election is here! The best deployment time has come. Which US stocks are worth paying attention to?
Bank of America stated that the average monthly ROI of the S&P 500 index in the fourth year of a presidential cycle shows mediocre performance from January to May, a summer rebound from June to August, a fall before the election in September to October, and a post-election rebound in November and December.
Deutsche Bank's Fresh Money List for 3Q
Insights Into Merck & Co's Performance Versus Peers In Pharmaceuticals Sector
In the fast-paced and cutthroat world of business, conducting thorough company analysis is essential for investors and industry experts. In this article, we will undertake a comprehensive industry com
Merck (MRK) Gets Exclusive Rights to Opevesostat From Partner
Merck and partner Orion Corporation announced that they have agreed to mutually exercise the option that will provide Merck global exclusive rights to develop and commercialize opevesostat (previously MK-5684)
5 Biggest Winners, 5 Biggest Losers From Dow Jones Industrial Average In First Half 2024
Broad stock market indexes like the S&P 500 hit all-time highs in the first half of 2024.The Dow Jones Industrial Average also hit all-time highs, but saw a smaller return in the first half of the yea